Literature DB >> 17505405

Palliative care provision in Huntington's disease.

Elizabeth Travers1, Kate Jones, Jacqueline Nichol.   

Abstract

There is currently much interest regarding the needs of people affected by non-malignant disease and whether or not these are being met by palliative care services. The evidence available appears to support the conclusion that while there is a general inequality of access, some individuals with non-malignant conditions such as cardiac disease and motor neurone disease are able to access palliative care services more readily than others. Huntington's disease (HD) is a devastating neurological condition of long duration and as such may have a lengthy palliative phase. Consequently, a diagnosis of HD will have a major impact on the quality of life of the affected individual and their family. For carers, an understanding of this challenging disease and its prognosis is essential for the provision of appropriate and effective care. This article reviews the links between HD and palliative care and discusses some of the challenges facing patients, families and health care professionals in adopting a palliative approach in the management of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17505405     DOI: 10.12968/ijpn.2007.13.3.23274

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  3 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Need for palliative care for neurological diseases.

Authors:  Leandro Provinciali; Giulia Carlini; Daniela Tarquini; Carlo Alberto Defanti; Simone Veronese; Eugenio Pucci
Journal:  Neurol Sci       Date:  2016-06-14       Impact factor: 3.307

3.  Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort.

Authors:  Filipe Brogueira Rodrigues; Daisy Abreu; Joana Damásio; Nilza Goncalves; Leonor Correia-Guedes; Miguel Coelho; Joaquim J Ferreira
Journal:  Mov Disord Clin Pract       Date:  2017-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.